帕金森病伴轻度认知障碍患者神经精神症状特征与认知下降的关联
该回顾性研究纳入单中心338例帕金森病伴轻度认知障碍患者,对12项神经精神量表症状进行因子分析,得到心境、活动过度相关和精神病性3个因子。分析显示心境和活动过度因子高负担与多个认知域得分较低相关,且心境、活动过度及精神病性因子严重度与痴呆转化风险升高相关。
要点
- 心境症状因子患病率较高与言语记忆和执行域得分较低相关。
- 活动过度相关症状严重度较高与命名、视空间和言语记忆域得分较低相关。
- 心境和活动过度因子患病率较高及精神病性因子严重度较高与痴呆转化风险升高相关。
核心结论
- 本研究表明,神经精神症状负担较高与帕金森病伴轻度认知障碍患者的痴呆转化相关。
研究设计与样本
- 回顾性评估单中心三级医院338例帕金森病伴轻度认知障碍患者,均接受神经心理测试和神经精神量表问卷。
- 对12项神经精神量表症状的二分类存在情况进行因子分析,得到3个因子:因子1心境症状、因子2活动过度相关症状、因子3精神病性症状;对症状严重度进行因子分析也识别出相似因子。
主要发现
- 因子1患病率评分较高与言语记忆域得分较低相关(β=-0.15,95%CI -0.24至-0.06,p=0.001)及执行域得分较低相关(β=-0.16,95%CI -0.28至-0.04,p=0.007)。
- 因子2严重度评分较高与命名域得分较低相关(β=-0.16,95%CI -0.28至-0.03,p=0.012)、视空间域得分较低相关(β=-0.24,95%CI -0.41至-0.07,p=0.005)及言语记忆域得分较低相关(β=-0.15,95%CI -0.24至-0.05,p=0.005)。
- 因子3严重度评分较高与视空间域得分较低相关(β=-0.25,95%CI -0.46至-0.07,p=0.007)。
- 调整年龄、性别、教育、病程、认知和帕金森病评分及左旋多巴等效剂量后,因子1患病率评分较高者痴呆风险升高(HR=1.48,95%CI 1.17-1.88,p=0.001),因子2患病率评分较高者痴呆风险升高(HR=1.27,95%CI 1.07-1.51,p=0.007),因子3严重度评分较高者痴呆风险升高(HR=1.52,95%CI 1.29-1.80,p<0.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Neuropsychiatric symptoms (NPS) are closely associated with cognitive decline in patients with Parkinson disease (PD). We investigated which profiles of NPS are associated with the risk of dementia in PD with mild cognitive impairment (PD-MCI). METHODS: We retrospectively assessed 338 patients with PD-MCI from a single tertiary hospital, who underwent neuropsychological tests and a neuropsychiatric inventory (NPI) questionnaire. We conducted a factor analysis of the dichotomized presence of 12 NPI symptoms, yielding 3 NPI factors: factor 1, mood symptoms; factor 2, hyperactivity-related symptoms; and factor 3, psychotic symptoms. Factor analysis of the severity of NPI symptoms also identified similar NPI factors. The neuropsychiatric correlates of NPI factors were evaluated using general linear models for cognitive tests. Subsequently, we evaluated the hazard ratio (HR) of NPI factors on conversion to dementia. RESULTS: A higher prevalence factor 1 score was associated with lower scores in the verbal memory (β = -0.15; 95% CI -0.24 to -0.06; p = 0.001) and executive domains (β = -0.16; 95% CI -0.28 to -0.04; p = 0.007), whereas higher severity factor 2 scores were associated with lower scores in the naming (β = -0.16; 95% CI -0.28 to -0.03; p = 0.012), visuospatial (β = -0.24; 95% CI -0.41 to -0.07; p = 0.005), and verbal memory domains (β = -0.15; 95% CI -0.24 to -0.05; p = 0.005). A higher severity factor 3 score was associated with lower scores in the visuospatial domain (β = -0.25; 95% CI -0.46 to -0.07; p = 0.007). Cox regression models demonstrated that the risk of dementia was increased in those with higher prevalence factor 1 (HR = 1.48, 95% CI 1.17-1.88, p = 0.001) and factor 2 scores (HR = 1.27, 95% CI 1.07-1.51, p = 0.007) and severity factor 3 score (HR = 1.52, 95% CI 1.29-1.80, p < 0.001) after adjusting for age, sex, education, disease duration, scores for cognition and parkinsonism, and levodopa equivalent dose. DISCUSSION: This study demonstrated that a higher burden of NPS is associated with dementia conversion in patients with PD-MCI.
引用
- Lee YG, Park M, Jeong SH, et al. Association of Neuropsychiatric Symptom Profiles With Cognitive Decline in Patients With Parkinson Disease and Mild Cognitive Impairment. Neurology. 2023. PMID: 37524535. doi:10.1212/WNL.0000000000207623
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。